Biocon strategy seemed to be very strong - to help ensure for organization to go ahead with trials , ensure commercialization of the products , on with sharing of the IPR . As the do drugs went from material body 1 to phase 3 , the number of subjects were increased . Phase 4 trials include researching the drug after it was marketed to obtain data about the side-effects , qualification and long-term riding habit . Since , it was a tender molecule , several(prenominal) experts in the field of crab lo subroutine were questioning about tolerant the drug to patients . However , Biocon tied up with premier cancer institutes in India such as Kidwai give of Oncology and used the drug for phase 2 trials . Clinigene aided in researching the drug The drug was combined with early(a) treatment modalities and it was anchor that when administered with radiotherapy-chemotherapy combination it could speed of light get rid of the cancer . However , BIOMAb had to argue with Erbitux which was internationally reputed . Biocon also considered whether BIOMAb could be employ for treating colorectal cancers and hence at one time compete with Erbitux .
If BIOMAb was launched after phase-2 trials , hence Erbitux may have been as it had faultless phase 3 trials . There was also the mentation of intro BIOMAb with other generic drugs simultaneously which could help the users to use the generic version and get accomplished with the drug . The caller ha d problems deciding to expenditure the drug! . If it was set below the price of Erbitux , then it would lose its credibility and in case it was higher(prenominal) it would not be affordable for the Indian public . so , it chose a two-tier price system for India so that certain plenty from the lower socioeconomic groups could even afford the drug and use it . There were two supply chains for BIOMAb , one by dint of the traditional manufacturer-wholesaler-pharmacy and the other a doctor...If you want to get a full essay, severalize it on our website: OrderCustomPaper.com
If you want to get a full essay, visit our page: write my paper
No comments:
Post a Comment